Your Search Results

Artificial intelligence and advanced imaging in coronary interventions

19 May 2026 – From EuroPCR 2026

This session explores the integration of artificial intelligence with advanced imaging modalities in coronary interventions. Topics include quantitative myocardial blood flow assessment via co-registered CCTA and angiography, AI-guided real-time procedural support, novel video frame interpolation techniques, high-risk plaque identification through AI-derived OCT stress mapping, and validation...

STEMI presenting with cardiogenic shock

19 May 2026 – From EuroPCR 2026

This session covers acute management of STEMI presenting with cardiogenic shock, illustrating advanced interventional strategies and support devices such as ECMO, IABP, and Impella. It reviews complex clinical scenarios including acute left main occlusion and multivessel disease, offering critical insights into emergent care and decision-making.

Stent failure evaluation with intracoronary imaging

19 May 2026 – From EuroPCR 2026

This session provides an in-depth evaluation of stent failure using intracoronary imaging modalities such as IVUS and OCT. It presents diverse cases illustrating late drug-eluting stent failure, in-stent restenosis, neoatherosclerosis, and complications following rotational atherectomy, underscoring imaging's role in diagnosis and guiding reintervention.

Leaflet modification techniques during TAVI

19 May 2026 – From EuroPCR 2026

This session explores leaflet modification techniques during TAVI, focusing on complex valve-in-valve procedures supported by artificial intelligence-powered planning and advanced imaging. Case discussions cover challenges such as low valve-to-coronary distances, bi-leaflet obstruction, and strategies to maintain coronary flow and hemodynamic stability.

Transcatheter mitral valve replacement - LIVE case

20 May 2026 – From EuroPCR 2026

A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).

A transcatheter mitral...

Transcatheter mitral valve replacement - LIVE case

Pulmonary valve: the next frontier in adult structural interventions

19 May 2026 – From EuroPCR 2026

This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.

New techniques and tips in CTO PCI

19 May 2026 – From EuroPCR 2026

This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices

20 May 2026 – From EuroPCR 2026

This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic...

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices

2026 Andreas Grüntzig Ethica Awardee: Roxana Mehran

20 May 2026

The Andreas Grüntzig Ethica Award – the highest honour in the interventional cardiology community – is presented to individuals who have contributed in an extraordinary way to the PCR mission.

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.